Skip to Content
· Biorevitalisation
SKU 11212

Viscoderm 2.0

In stock
Volume
3 x 1 mL
Laboratory
IBSA
Origin
Italy
Indication
Mature and dehydrated skin, reduced elasticity
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Viscoderm 2.0 is an injectable gel implant by Viscoderm for skin biorevitalisation, formulated with native hyaluronic acid at 2.0% obtained through biofermentation from natural raw materials. It is frequently chosen by clinics, dermatologists and aesthetic practitioners for mature, dehydrated or age-affected skin requiring stronger restructuring and hydrating support. The product is designed for use on the perioral and peri-orbital areas, nasolabial folds, forehead, neck, hands and decollete, and is intended for professional use by qualified practitioners.

Key Benefits of Viscoderm 2.0

  • Native hyaluronic acid at 2.0%, the strongest concentration in the Viscoderm injectable range
  • Provides intensive skin hydration
  • Improves skin elasticity
  • Supports skin restructuring in mature or dehydrated skin
  • Helps prevent the signs of epidermal ageing
  • Suitable for multiple facial and body treatment areas
  • Visible results may be observed after the second procedure
  • Hyaluronic acid obtained by biofermentation from natural raw materials
Key Information
Brand Viscoderm
Manufacturer IBSA
Country of Origin Italy
Certification Classified as a medical product
Ingredients Native hyaluronic acid, obtained by biofermentation from natural raw materials
Volume / Size 1 ml per pre-filled syringe, 3 ml per pack
Packaging 3 pre-filled syringes x 1 ml, with 6 needles 30G x 12 mm
Needle Size 30G x 12 mm, 6 needles supplied per pack
Use Type Professional use only, by qualified practitioners. Pre-filled single-use syringes.
Protocol / Duration Visible results may be observed after the second procedure

Indications and Professional Use

Main indications

  • Mature or dehydrated skin
  • Reduced skin elasticity
  • Signs of skin ageing
  • Skin requiring stronger restructuring and hydrating support
  • Prevention of epidermal ageing

Professional use

Viscoderm 2.0 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. It is supplied in pre-filled single-use syringes, aseptic technique applies throughout, and any unused content is discarded. The treating practitioner determines the injection technique, plane, dose per point and session interval for each indication and treated area, including for the peri-orbital and perioral areas, which are delicate zones. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and in patients using anticoagulant or antiplatelet medication.

Treatment areas

  • Perioral area
  • Nasolabial folds
  • Peri-orbital area
  • Forehead
  • Neck
  • Hands
  • Decollete

Patient profile

Viscoderm 2.0 is intended for adult patients with mature, dehydrated or age-affected skin, reduced elasticity or visible signs of skin ageing, where stronger restructuring and hydrating support is the treatment goal. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood clotting disorders, or in patients taking anticoagulants or antiplatelet medication.

How Viscoderm 2.0 Works

Viscoderm 2.0 works through native hyaluronic acid at 2.0%, obtained by biofermentation from natural raw materials. Injected into the dermis, it restores the skin's hyaluronic acid reserve and binds water in the tissue, which provides intensive hydration and improves elasticity while supporting restructuring of mature or dehydrated skin. As the strongest concentration in the Viscoderm injectable range, it is suited to skin that needs more structural support than the 0.8 and 1.6 concentrations provide, and visible results may be observed after the second procedure.

Why Order From Allpara

Allpara offers genuine, verified VISCODERM products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?

Viscoderm 2.0 contains native hyaluronic acid at 2.0%, the strongest concentration in the range, and is intended for mature or dehydrated skin needing stronger restructuring. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe for moderate age-related change, and Viscoderm 0.8 contains 8 mg/ml for especially thin and delicate skin and preventive protocols.

Which areas can Viscoderm 2.0 be used on?

Viscoderm 2.0 is used on the perioral area, nasolabial folds, the peri-orbital area, the forehead, the neck, the hands and the decollete.

When are results from Viscoderm 2.0 visible?

Visible results may be observed after the second procedure, with the treatment course determined by the practitioner for the patient and area treated.

What does a Viscoderm 2.0 pack contain?

Each pack contains 3 pre-filled syringes of 1 ml and 6 needles of 30G x 12 mm.

Who should not be treated with Viscoderm 2.0?

Viscoderm 2.0 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and use of anticoagulant or antiplatelet medication.

/ Specifications

The datasheet

Brand
VISCODERM
Laboratory
IBSA
SKU
11212
Format
3 x 1 mL
Origin
Italy
Indication
Mature and dehydrated skin, reduced elasticity
Use
Injectable gel implant, professional use
/ Product details

The full file

Viscoderm 2.0 is an injectable gel implant by Viscoderm for skin biorevitalisation, formulated with native hyaluronic acid at 2.0% obtained through biofermentation from natural raw materials. It is frequently chosen by clinics, dermatologists and aesthetic practitioners for mature, dehydrated or age-affected skin requiring stronger restructuring and hydrating support. The product is designed for use on the perioral and peri-orbital areas, nasolabial folds, forehead, neck, hands and decollete, and is intended for professional use by qualified practitioners.

IBSA, country of origin Italy.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?

Viscoderm 2.0 contains native hyaluronic acid at 2.0%, the strongest concentration in the range, and is intended for mature or dehydrated skin needing stronger restructuring. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe for moderate age-related change, and Viscoderm 0.8 contains 8 mg/ml for especially thin and delicate skin and preventive protocols.

Which areas can Viscoderm 2.0 be used on?

Viscoderm 2.0 is used on the perioral area, nasolabial folds, the peri-orbital area, the forehead, the neck, the hands and the decollete.

When are results from Viscoderm 2.0 visible?

Visible results may be observed after the second procedure, with the treatment course determined by the practitioner for the patient and area treated.

What does a Viscoderm 2.0 pack contain?

Each pack contains 3 pre-filled syringes of 1 ml and 6 needles of 30G x 12 mm.

Who should not be treated with Viscoderm 2.0?

Viscoderm 2.0 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and use of anticoagulant or antiplatelet medication.

/ Quick answers

Everything a buyer asks first

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?
Viscoderm 2.0 contains native hyaluronic acid at 2.0%, the strongest concentration in the range, and is intended for mature or dehydrated skin needing stronger restructuring. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe for moderate age-related change, and Viscoderm 0.8 contains 8 mg/ml for especially thin and delicate skin and preventive protocols.
Which areas can Viscoderm 2.0 be used on?
Viscoderm 2.0 is used on the perioral area, nasolabial folds, the peri-orbital area, the forehead, the neck, the hands and the decollete.
When are results from Viscoderm 2.0 visible?
Visible results may be observed after the second procedure, with the treatment course determined by the practitioner for the patient and area treated.
/ FAQ

Frequently asked

Viscoderm 2.0 contains native hyaluronic acid at 2.0%, the strongest concentration in the range, and is intended for mature or dehydrated skin needing stronger restructuring. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe for moderate age-related change, and Viscoderm 0.8 contains 8 mg/ml for especially thin and delicate skin and preventive protocols.
Viscoderm 2.0 is used on the perioral area, nasolabial folds, the peri-orbital area, the forehead, the neck, the hands and the decollete.
Visible results may be observed after the second procedure, with the treatment course determined by the practitioner for the patient and area treated.
Each pack contains 3 pre-filled syringes of 1 ml and 6 needles of 30G x 12 mm.
Viscoderm 2.0 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and use of anticoagulant or antiplatelet medication.

More from IBSA

View laboratory

Clinic alternatives

All products

Viscoderm 2.0

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Viscoderm 2.0 is an injectable gel implant by Viscoderm for skin biorevitalisation, formulated with native hyaluronic acid at 2.0% obtained through biofermentation from natural raw materials. It is frequently chosen by clinics, dermatologists and aesthetic practitioners for mature, dehydrated or age-affected skin requiring stronger restructuring and hydrating support. The product is designed for use on the perioral and peri-orbital areas, nasolabial folds, forehead, neck, hands and decollete, and is intended for professional use by qualified practitioners.

Key Benefits of Viscoderm 2.0

  • Native hyaluronic acid at 2.0%, the strongest concentration in the Viscoderm injectable range
  • Provides intensive skin hydration
  • Improves skin elasticity
  • Supports skin restructuring in mature or dehydrated skin
  • Helps prevent the signs of epidermal ageing
  • Suitable for multiple facial and body treatment areas
  • Visible results may be observed after the second procedure
  • Hyaluronic acid obtained by biofermentation from natural raw materials
Key Information
Brand Viscoderm
Manufacturer IBSA
Country of Origin Italy
Certification Classified as a medical product
Ingredients Native hyaluronic acid, obtained by biofermentation from natural raw materials
Volume / Size 1 ml per pre-filled syringe, 3 ml per pack
Packaging 3 pre-filled syringes x 1 ml, with 6 needles 30G x 12 mm
Needle Size 30G x 12 mm, 6 needles supplied per pack
Use Type Professional use only, by qualified practitioners. Pre-filled single-use syringes.
Protocol / Duration Visible results may be observed after the second procedure

Indications and Professional Use

Main indications

  • Mature or dehydrated skin
  • Reduced skin elasticity
  • Signs of skin ageing
  • Skin requiring stronger restructuring and hydrating support
  • Prevention of epidermal ageing

Professional use

Viscoderm 2.0 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. It is supplied in pre-filled single-use syringes, aseptic technique applies throughout, and any unused content is discarded. The treating practitioner determines the injection technique, plane, dose per point and session interval for each indication and treated area, including for the peri-orbital and perioral areas, which are delicate zones. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and in patients using anticoagulant or antiplatelet medication.

Treatment areas

  • Perioral area
  • Nasolabial folds
  • Peri-orbital area
  • Forehead
  • Neck
  • Hands
  • Decollete

Patient profile

Viscoderm 2.0 is intended for adult patients with mature, dehydrated or age-affected skin, reduced elasticity or visible signs of skin ageing, where stronger restructuring and hydrating support is the treatment goal. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood clotting disorders, or in patients taking anticoagulants or antiplatelet medication.

How Viscoderm 2.0 Works

Viscoderm 2.0 works through native hyaluronic acid at 2.0%, obtained by biofermentation from natural raw materials. Injected into the dermis, it restores the skin's hyaluronic acid reserve and binds water in the tissue, which provides intensive hydration and improves elasticity while supporting restructuring of mature or dehydrated skin. As the strongest concentration in the Viscoderm injectable range, it is suited to skin that needs more structural support than the 0.8 and 1.6 concentrations provide, and visible results may be observed after the second procedure.

Why Order From Allpara

Allpara offers genuine, verified VISCODERM products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?

Viscoderm 2.0 contains native hyaluronic acid at 2.0%, the strongest concentration in the range, and is intended for mature or dehydrated skin needing stronger restructuring. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe for moderate age-related change, and Viscoderm 0.8 contains 8 mg/ml for especially thin and delicate skin and preventive protocols.

Which areas can Viscoderm 2.0 be used on?

Viscoderm 2.0 is used on the perioral area, nasolabial folds, the peri-orbital area, the forehead, the neck, the hands and the decollete.

When are results from Viscoderm 2.0 visible?

Visible results may be observed after the second procedure, with the treatment course determined by the practitioner for the patient and area treated.

What does a Viscoderm 2.0 pack contain?

Each pack contains 3 pre-filled syringes of 1 ml and 6 needles of 30G x 12 mm.

Who should not be treated with Viscoderm 2.0?

Viscoderm 2.0 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and use of anticoagulant or antiplatelet medication.

More from IBSA

View laboratory →

Viscoderm 2.0 is an injectable gel implant by Viscoderm for skin biorevitalisation, formulated with native hyaluronic acid at 2.0% obtained through biofermentation from natural raw materials. It is frequently chosen by clinics, dermatologists and aesthetic practitioners for mature, dehydrated or age-affected skin requiring stronger restructuring and hydrating support. The product is designed for use on the perioral and peri-orbital areas, nasolabial folds, forehead, neck, hands and decollete, and is intended for professional use by qualified practitioners.

IBSA, country of origin Italy.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

How does Viscoderm 2.0 differ from Viscoderm 0.8 and 1.6?

Viscoderm 2.0 contains native hyaluronic acid at 2.0%, the strongest concentration in the range, and is intended for mature or dehydrated skin needing stronger restructuring. Viscoderm 1.6 contains 24 mg per 1.5 ml syringe for moderate age-related change, and Viscoderm 0.8 contains 8 mg/ml for especially thin and delicate skin and preventive protocols.

Which areas can Viscoderm 2.0 be used on?

Viscoderm 2.0 is used on the perioral area, nasolabial folds, the peri-orbital area, the forehead, the neck, the hands and the decollete.

When are results from Viscoderm 2.0 visible?

Visible results may be observed after the second procedure, with the treatment course determined by the practitioner for the patient and area treated.

What does a Viscoderm 2.0 pack contain?

Each pack contains 3 pre-filled syringes of 1 ml and 6 needles of 30G x 12 mm.

Who should not be treated with Viscoderm 2.0?

Viscoderm 2.0 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to develop hypertrophic or keloid scars, blood clotting disorders, and use of anticoagulant or antiplatelet medication.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.